About Step Pharma

Step Pharma is discovering and developing novel therapeutics that inhibit the enzyme CTP Synthase 1 (CTPS1).

Step Pharma was created on the basis of research on genetic immunodeficiencies led by Prof. Alain Fischer at the Imagine Institute (Paris, France) which established the essential role of CTPS1 in T- and B-cell proliferation.

Read more about us

Latest news

5 September 2019

Step Pharma Appoints Seasoned Drug Developer Dr. Andrew Parker as Chief Executive Officer

Paris, France, 6 September 2019 – Step Pharma, a biotech company developing novel drugs for autoimmune diseases, today…

Read more

25 February 2018

Step Pharma Establishes Scientific Advisory Board

Paris, France, 25th February 2018 - Step Pharma, a company focused on the development new oral treatments of a range of…

Read more

21 November 2017

Step Pharma Completes €14.5 million Series A Financing with Additional New Investor

Paris, France, 21 November 2017 – Step Pharma today announced the closing of a Series A financing totalling €14.5…

Read more

Upcoming events

Step Pharma will be present at the following events

Share this page

Step Pharma

Forum 2
218 avenue Marie Curie
74160 Archamps
France

Contact us for more information